MedPath

LIPOSYN II INJ 10%

LIPOSYN II INJ 10%

Discontinued
DIN Number

00818712

Drug Class

Human

Market Date

Jan 1, 1992

Company
HC

hospira healthcare ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00818712
AIG Number0318894003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05BA02 FAT EMULSIONS
Product Specifications
Dosage FormEmulsion
Route of AdministrationIntravenous
AHFS Classification40:20.00
Health Canada Classification

ACTIVE INGREDIENTS (3)

EGG PHOSPHOLIPIDSActive
Strength: 700 MG / 100 ML
Monograph: EGG PHOSPHOLIPIDS
SAFFLOWER OILActive
Strength: 5.0 G / 100 ML
Monograph: SAFFLOWER OIL
SOYBEAN OILActive
Strength: 5.0 G / 100 ML
Monograph: SOYBEAN OIL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.